Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 5
1958 4
1959 1
1960 2
1962 4
1963 1
1964 4
1965 3
1966 2
1967 1
1968 2
1969 3
1970 3
1971 4
1972 7
1973 8
1974 4
1975 9
1976 6
1977 2
1978 11
1979 12
1980 14
1981 12
1982 28
1983 19
1984 19
1985 26
1986 36
1987 32
1988 46
1989 47
1990 53
1991 36
1992 87
1993 70
1994 88
1995 83
1996 89
1997 88
1998 98
1999 99
2000 119
2001 104
2002 152
2003 185
2004 196
2005 276
2006 315
2007 325
2008 347
2009 368
2010 447
2011 565
2012 556
2013 619
2014 739
2015 806
2016 853
2017 977
2018 1046
2019 1199
2020 1499
2021 1701
2022 1923
2023 1876
2024 1512
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

17,805 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. Among authors: huang m. N Engl J Med. 2024 Aug 15;391(7):585-597. doi: 10.1056/NEJMoa2402614. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828946 Clinical Trial.
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis.
Wang X, Wu X, Tan B, Zhu L, Zhang Y, Lin L, Xiao Y, Sun A, Wan X, Liu S, Liu Y, Ta N, Zhang H, Song J, Li T, Zhou L, Yin J, Ye L, Lu H, Hong J, Cheng H, Wang P, Li W, Chen J, Zhang J, Luo J, Huang M, Guo L, Pan X, Jin Y, Ye W, Dai L, Zhu J, Sun L, Zheng B, Li D, He Y, Liu M, Wu H, Du B, Xu H. Wang X, et al. Among authors: huang m. Cell. 2024 Sep 5;187(18):4890-4904.e9. doi: 10.1016/j.cell.2024.06.027. Epub 2024 Jul 15. Cell. 2024. PMID: 39013470
Emerging delivery strategy for oncolytic virotherapy.
Zhu J, Ma J, Huang M, Deng H, Shi G. Zhu J, et al. Among authors: huang m. Mol Ther Oncol. 2024 Apr 29;32(2):200809. doi: 10.1016/j.omton.2024.200809. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38845744 Free PMC article. Review.
The role of NCAPH in cancer treatment.
Liu C, Han X, Zhang S, Huang M, Guo B, Zhao Z, Yang S, Jin J, Pu W, Yu H. Liu C, et al. Among authors: huang m. Cell Signal. 2024 Sep;121:111262. doi: 10.1016/j.cellsig.2024.111262. Epub 2024 Jun 18. Cell Signal. 2024. PMID: 38901722 Review.
The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.
Yu S, Sun Z, Ju T, Liu Y, Mei Z, Wang C, Qu Z, Li N, Wu F, Liu K, Lu M, Huang M, Pang X, Jia Y, Li Y, Zhang Y, Dou S, Jiang J, Dong X, Huang C, Li W, Zhang Y, Yuan Y, Yang B, Du W. Yu S, et al. Among authors: huang m. Adv Sci (Weinh). 2024 Aug;11(29):e2308769. doi: 10.1002/advs.202308769. Epub 2024 May 29. Adv Sci (Weinh). 2024. PMID: 38810124 Free PMC article.
Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.
LeSavage BL, Zhang D, Huerta-López C, Gilchrist AE, Krajina BA, Karlsson K, Smith AR, Karagyozova K, Klett KC, Huang MS, Long C, Kaber G, Madl CM, Bollyky PL, Curtis C, Kuo CJ, Heilshorn SC. LeSavage BL, et al. Among authors: huang ms. Nat Mater. 2024 Aug;23(8):1138-1149. doi: 10.1038/s41563-024-01908-x. Epub 2024 Jul 4. Nat Mater. 2024. PMID: 38965405
17,805 results
You have reached the last available page of results. Please see the User Guide for more information.